Global Market Presence Nova Eye Medical's technologies are used by eye surgeons in over 100 countries, indicating a strong international footprint and a wide potential customer base for expanding sales efforts.

Recent Product Launches The launch of innovative devices like the iTrack Advance and iTrack canaloplasty microcatheter demonstrates ongoing product development, providing opportunities to target surgical centers seeking latest glaucoma treatments.

Research & Validation Publication of six-year data on the iTrack canaloplasty microcatheter enhances product credibility, which can be leveraged to build trust and accelerate adoption among ophthalmic professionals.

Funding & Expansion Recent financing rounds totaling over $14 million support Nova Eye's plans for global expansion, pointing to opportunities for sales growth in new markets and increased product outreach.

Strategic Industry Engagement Active participation in major ophthalmology congresses like DOG and ESCRS positions Nova Eye for visibility among key decision-makers, facilitating relationship-building and new customer acquisition.